Overview

Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone

Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
In the NeoAPBI 01 trial, the objective is to demonstrate the efficacy of combined APBI and CT administered sequentially in patients with intermediate ad high risk BC. The hypothesis is that combined PST-sequential APBI may increase the rate of pCR, breast conservation and survival without additional toxicity, as seen with WBI
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University Hospital, Grenoble